A phase I study (E011-MEL) of a TriMix-based mRNA immunotherapy (ECI-006) in resected melanoma patients: Analysis of safety and immunogenicity.

标题
A phase I study (E011-MEL) of a TriMix-based mRNA immunotherapy (ECI-006) in resected melanoma patients: Analysis of safety and immunogenicity.
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 37, Issue 15_suppl, Pages 2641-2641
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2019-05-27
DOI
10.1200/jco.2019.37.15_suppl.2641

向作者/读者发起求助以获取更多资源

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started